Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2000, p. 3577-3580, Vol. 38, No. 10
Centers for Disease Control and Prevention,
Atlanta, Georgia
Received 25 February 2000/Returned for modification 18 May
2000/Accepted 4 August 2000
The MicroScan Rapid Neg ID3 panel (Dade Behring, Inc., West
Sacramento, Calif.) is designed for the identification of gram-negative bacilli. We evaluated its ability to accurately identify
Enterobacteriaceae that are routinely encountered in a
clinical laboratory and glucose nonfermenting gram-negative bacilli.
Using 511 stock cultures that were maintained at
0095-1137/00/$04.00+0
Evaluation of the MicroScan Rapid Neg ID3 Panel for
Identification of Enterobacteriaceae and Some Common
Gram-Negative Nonfermenters
70°C and passaged
three times before use, we inoculated panels according to the
manufacturer's instructions and processed them in a Walk/Away
instrument using version 22.01 software. The time to identification was
2 h and 30 min. All panel identifications were compared to
reference identifications previously determined by conventional tube
biochemicals. At the end of the initial 2.5-h incubation period, 405 (79.3%) identifications were correct. An additional 49 (9.6%)
isolates were correctly identified after required additional off-line
biochemical tests were performed. Thus, at 24 h, 88.8% of the 511 strains tested were correctly identified. Twenty-two (4.3%) were
identified to the genus level only. Twenty-six (5.1%) strains were
misidentified. Because the system is based on fluorogenics, there are
no conventional tests readily available with which to compare possibly
incorrect reactions. Of the 28 Salmonella strains that were
tested, 5 were incorrectly reported. The 21 remaining errors were
scattered among the genera tested. Testing on nine strains gave a
result of "no identification" (very rare biotype). The Rapid Neg
ID3 panel in this study approached 89% accuracy for the identification
of gram-negative organisms encountered in the hospital laboratory.
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, Mailstop C16, Atlanta, GA 30333. Phone: (404) 639-2316. Fax: (404) 639-3241. E-mail: cmo1{at}cdc.gov.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|